Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2017-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14787210.2017.1328278PMID 28480779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

  2017cited by this paper
• Zika Virus Diseases – The New Face of an Ancient Enemy as Global Public Health Emergency (2016): Brief Review and Recent Updates

  2017cited by this paper
• Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity

  2017cited by this paper
• Tick-borne encephalitis virus neutralization by high dose intravenous immunoglobulin.

  2017influential reference
• Successful Treatment of Brachial Plexopathy Due to Herpes Zoster Infection With Intravenous Immunoglobulin

  2016cited by this paper
• Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

  2016cited by this paper
• Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

  2016cited by this paper
• Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

  2016cited by this paper
• Convalescent Ebola plasma: assessing neutralizing antibodies at the right stage

  2016cited by this paper
• Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

  2016cited by this paper
• Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

  2016cited by this paper
• The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries

  2016cited by this paper
• Commercially Available Immunoglobulins Contain Virus Neutralizing Antibodies Against All Major Genotypes of Polyomavirus BK

  2015cited by this paper
• New approaches to chikungunya virus vaccine development.

  2015cited by this paper
• The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease

  2015cited by this paper
• Successful treatment of disseminated adenovirus infection with ribavirin and intravenous immunoglobulin in an adult renal transplant recipient: a case report.

  2015cited by this paper
• A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.

  2014cited by this paper
• First Ebola treatment is approved by WHO

  2014cited by this paper
• Diverse Seizure Presentation of Acute Mycoplasma Pneumoniae Encephalitis Resolving With Immunotherapy

  2014cited by this paper
• Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults

  2014cited by this paper
• Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.

  2014cited by this paper
• Application of r‐PFE hyperimmune sera for concurrent detection of Bacillus anthracis, Yersinia pestis and staphylococcal enterotoxin B

  2014cited by this paper
• Low Levels of Antibody-Dependent Enhancement in Vitro Using Viruses and Plasma from Dengue Patients

  2014cited by this paper
• Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model.

  2014cited by this paper
• Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity

  2013cited by this paper
• Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report.

  2013cited by this paper
• Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

  2013cited by this paper
• [Toxic epidermal necrolysis associated with acute infection by Mycoplasma pneumoniae].

  2013cited by this paper
• Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.

  2013cited by this paper
• Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection

  2013cited by this paper
• Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax

  2013cited by this paper
• May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

  2013cited by this paper
• Production of intravenous human dengue immunoglobulin from Brazilian-blood donors

  2013cited by this paper
• Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever

  2013cited by this paper
• Amplification of 16S rDNA by nested PCR for measurement of Mycoplasma pneumoniae DNA over time: clinical application.

  2012cited by this paper
• Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis

  2012cited by this paper
• Production of Plasma Proteins for Therapeutic Use

  2012cited by this paper
• Hyperimmune Immunoglobulin G

  2012cited by this paper
• A Case of Acute Myopericarditis Associated With Mycoplasma Pneumoniae Infection in a Child

  2012cited by this paper
• Prevention of tetanus during the First World War

  2012cited by this paper
• A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.

  2011cited by this paper
• Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

  2011cited by this paper
• Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency.

  2011cited by this paper
• Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR.

  2011cited by this paper
• Safety and Efficacy of HIV Hyperimmune Globulin for Prevention of Mother-to-Child HIV Transmission in HIV-1–Infected Pregnant Women and Their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)

  2011cited by this paper
• Severe Mycoplasma pneumoniae‐associated mucositis treated with immunoglobulins

  2011cited by this paper
• In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors.

  2011cited by this paper
• Prophylaxis of cytomegalovirus disease in mismatched patients after heart transplantation using combined antiviral and immunoglobulin therapy.

  2011cited by this paper
• Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.

  2010cited by this paper
• Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.

  2010cited by this paper
• Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin

  2010cited by this paper
• Intravenous immunoglobulin increases survival time in the acute phase of experimental Chagas disease

  2010cited by this paper
• Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection

  2010cited by this paper
• Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

  2010cited by this paper
• Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.

  2010cited by this paper
• Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

  2009cited by this paper
• Pathogenesis, Diagnosis, and Management of Primary Antibody Deficiencies and Infections

  2009cited by this paper
• Prophylaxis and Therapy for Chikungunya Virus Infection

  2009cited by this paper
• Successful treatment of Clostridium difficile colitis with intravenous immunoglobulin.

  2008cited by this paper
• THE USE OF HUMAN IMMUNE SERUM GLOBULIN

  2008cited by this paper
• Role of natural antibodies in immune homeostasis: IVIg perspective.

  2008cited by this paper
• An unusual cause for anaemia.

  2008cited by this paper
• Mycoplasma pneumoniae encephalopathy: recovery after intravenous immunoglobulin.

  2008cited by this paper
• Mycoplasma pneumoniae-associated transverse myelitis with unexpected rapid response to macrolide therapy: a case report.

  2008cited by this paper
• Antibodies for the treatment of bacterial infections: current experience and future prospects.

  2008cited by this paper
• Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock *

  2007cited by this paper
• Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens

  2007cited by this paper
• Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.

  2007cited by this paper
• Refractory Clostridium difficile-associated diarrhea.

  2007cited by this paper
• IS PERTUSSIS IMMUNE GLOBULIN EFFICACIOUS FOR THE TREATMENT OF HOSPITALIZED INFANTS WITH PERTUSSIS?: NO ANSWER YET

  2007cited by this paper
• Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review

  2007cited by this paper
• West Nile virus neutralization by US plasma-derived immunoglobulin products.

  2007cited by this paper
• A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.

  2007cited by this paper
• Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.

  2007cited by this paper
• Treatment of Argentine hemorrhagic fever

  2007cited by this paper
• Score‐based immunoglobulin G therapy of patients with sepsis: The SBITS study *

  2007cited by this paper
• Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.

  2007cited by this paper
• Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

  2006cited by this paper
• Intravenous immunoglobulin for resistant Clostridium difficile infection.

  2006cited by this paper
• Panton-Valentine leukocidin-producing Staphylococcus aureus infections: Report of 4 French cases

  2006cited by this paper
• Human botulism immune globulin for the treatment of infant botulism.

  2006cited by this paper
• Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea

  2006cited by this paper
• Successful treatment of avian influenza with convalescent plasma.

  2006cited by this paper
• Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital

  2005cited by this paper
• Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.

  2005cited by this paper
• EFFECTS OF HIGH-DOSE OF INTRAVENOUS IMMUNOGLOBULIN AND ANTIBIOTICS ON SURVIVAL FOR SEVERE SEPSIS UNDERGOING SURGERY

  2005cited by this paper
• Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.

  2005cited by this paper
• Passive immunization during pregnancy for congenital cytomegalovirus infection.

  2005cited by this paper
• Multicenter Study to Assess Safety and Efficacy of INH-A21, a Donor-Selected Human Staphylococcal Immunoglobulin, for Prevention of Nosocomial Infections in Very Low Birth Weight Infants

  2005cited by this paper
• Use of convalescent plasma therapy in SARS patients in Hong Kong

  2004cited by this paper
• IMMUNOGLOBULIN M–ENRICHED INTRAVENOUS POLYCLONAL IMMUNOGLOBULINS REDUCE BACTEREMIA FOLLOWING KLEBSIELLA PNEUMONIAE INFECTION IN AN ACUTE RESPIRATORY DISTRESS SYNDROME RAT MODEL

  2004cited by this paper
• Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea.

  2004cited by this paper
• Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin.

  2003cited by this paper
• Antibody-Dependent Enhancement of Ebola Virus Infection

  2003cited by this paper
• Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.

  2003cited by this paper
• Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

  2002cited by this paper
• Anthrax. 'Borrowed immunity' may save future victims.

  2002cited by this paper
• Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins.

  2002cited by this paper
• 'Borrowed Immunity' May Save Future Victims

  2002cited by this paper

• New Technologies in Therapeutic Antibody Development: The Next Frontier for Treating Infectious Diseases.

  2024cites this paper
• Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series

  2023cites this paper
• Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development

  2023cites this paper
• GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2

  2022cites this paper
• Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation

  2022influential citation
• Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective

  2021cites this paper
• Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

  2021cites this paper
• Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial

  2021cites this paper
• Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

  2021cites this paper
• Characterization of antibodies in human immunoglobulin products from different regions worldwide

  2021cites this paper
• Short Communication Treatment with convalescent plasma for COVID-19 with respect to experience from prior coronavirus epidemics

  2021cites this paper
• Generation of recombinant hyperimmune globulins from diverse B-cell repertoires

  2021cites this paper
• Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases

  2021cites this paper
• Dengue: actualidades y estándares en el manejo clínico. Revisión de tema

  2020cites this paper
• Viejos remedios para nuevos males. El caso del plasma de convalecientes

  2020cites this paper
• Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

  2020cites this paper
• Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration.

  2020cites this paper
• Pivotal role of convalescent plasma in managing emerging infectious diseases

  2020cites this paper
• Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens

  2020cites this paper
• Screening of multiple hemoprotein-specific aptamers and their applications for the binding, quantification, and extraction of hemoproteins in a microfluidic system.

  2020cites this paper
• Medicamentos versátiles: buscando balas mágicas

  2020cites this paper
• Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens

  2020cites this paper
• Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges

  2020cites this paper
• Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins

  2020cites this paper
• Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development

  2020cites this paper
• Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks

  2020cites this paper
• COVID-19 Convalescent Plasma EUA Decision Memo

  2020influential citation
• Capturing and Recreating Diverse Antibody Repertoires as Multivalent Recombinant Polyclonal Antibody Drugs

  2020cites this paper
• Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins.

  2019cites this paper
• Zika virus: An emerging infectious disease with serious perinatal and neurologic complications

  2017cites this paper